Skip to content

Contact +44 (0) 20 7060 7474 email us

Medical Devices

Republic of Korea Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012

 

Publication Date December 2008
Publisher Global Markets Direct
Product Type Report
Pages 69
ISBN Number not applicable
Product Code GMD01565

Price

£1,995.00
approximately: $2,998 | €2,187

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

Republic of Korea Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to the Republic of Korea drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices in Republic of Korea

Scope

  • The report provides drug delivery devices information broken down into detailed categories and segments in Republic of Korea.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the drug delivery devices market in Republic of Korea.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Contents

  • 1.1 List of Tables
  • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of the Markets Covered in the Report
    • 3.1 Drug delivery devices
    • 3.2 Inhalation Systems
      • 3.2.1 Metered Dose Inhaler
      • 3.2.2 Dry powder inhaler
    • 3.3 Infusion Systems
      • 3.3.1 Infusion pumps
      • 3.3.2 Syringe pumps
      • 3.3.3 Disposable Infusion sets
  • 4 Healthcare Sector Review
    • 4.1 Healthcare Expenditure
    • 4.2 Healthcare Infrastructure
    • 4.3 Healthcare Policy
  • 5 Regulation System
    • 5.1 Medical Equipment Approval Process
      • 5.1.1 Classification
      • 5.1.2 Premarket Notification for Class I Devices
      • 5.1.3 Pre-market Approval for Class II, III and IV Devices
      • 5.1.4 License Fee
      • 5.1.5 License Application Processing Duration
    • 5.2 Post-market Surveillance
  • 6 Pricing and Reimbursement
  • 7 Distribution Structure
    • 7.1 Distribution Structure
  • 8 Drug Delivery Devices In Republic of Korea
    • 8.1 Drug Delivery Devices Cross Country Comparison (2000-2012)
    • 8.2 Drug Delivery Devices, Republic of Korea, Overall Revenues ($ mn), 2000-2012
    • 8.3 Drug Delivery Devices, Republic of Korea, Category Volume (Units), 2000-2012
    • 8.4 Drug Delivery Devices, Republic of Korea, Company Share (2006-2007)
  • 9 Infusion Systems In Republic of Korea
    • 9.1 Infusion Systems Overall Revenue (2000-2012)
    • 9.2 Infusion Systems Overall Volume (2000-2012)
    • 9.3 Infusion Systems Average Price (2000-2012)
    • 9.4 Infusion Systems Distribution Share (2006-2007)
    • 9.5 Infusion Systems, Republic of Korea, Company Share (2006-2007)
  • 10 Inhalation Systems In Republic of Korea
    • 10.1 Inhalation Systems Overall Revenue (2000-2012)
    • 10.2 Inhalation Systems Overall Volume (2000-2012)
    • 10.3 Inhalation Systems Average Price (2000-2012)
    • 10.4 Inhalation Systems Distribution Share (2006-2007)
    • 10.5 Inhalation Systems, Republic of Korea, Company Share (2006-2007)
  • 11 3M Company Company Profile
    • 11.1 Company Overview
    • 11.2 Value Chain Analysis
      • 11.2.1 Manufacturing
      • 11.2.2 Product Development
      • 11.2.3 Sales and Marketing
  • 12 AstraZeneca PLC Company Profile
    • 12.1 Company Overview
  • 13 GlaxoSmithKline plc Company Profile
    • 13.1 Company Overview
  • 14 Boehringer Ingelheim GmbH Company Profile
    • 14.1 Company Overview
    • 14.2 Value Chain Analysis
      • 14.2.1 Manufacturing
      • 14.2.2 Product Development
      • 14.2.3 Sales and Marketing
  • 15 Novartis Medical Nutrition Company Profile
    • 15.1 Company Overview
  • 16 Cardinal Health, Inc. Company Profile
    • 16.1 Company Overview
    • 16.2 Value Chain Analysis
      • 16.2.1 Manufacturing
      • 16.2.2 Product Development
      • 16.2.3 Sales and Marketing
  • 17 Samyang Corporation Company Profile
    • 17.1 Company Overview
  • 18 Shin Chang Medical Co., Ltd. Company Profile
    • 18.1 Company Overview
  • 19 Woo Young Medical Co., Ltd. Company Profile
    • 19.1 Company Overview
  • 20 Appendix
    • 20.1 Global Markets Direct Research Methodology
    • 20.2 Coverage
    • 20.3 Secondary Research
    • 20.4 Primary Research
    • 20.5 Models
    • 20.6 Forecasts
    • 20.7 Expert Panels
    • 20.8 Currency Conversion
    • 20.9 Contact Us
    • 20.10 Disclaimer
  • 1.1 List of Tables
    • Table 1: Hospital Wards by Specialty in Republic of Korea, 2003-2007
    • Table 2: Doctors by Specialty in Republic of Korea, 2003-2007
    • Table 3: Healthcare Institutions in Republic of Korea, 2001-2005
    • Table 4: Healthcare Personnel in Republic of Korea, 1975-2002
    • Table 5: Classification of Medical Equipment in Republic of Korea
    • Table 6: Drug Delivery Devices Cross Country Comparison (2000-2012)
    • Table 7: Drug Delivery Devices, Republic of Korea, Overall Revenues ($ mn), 2000-2012
    • Table 8: Drug Delivery Devices, Republic of Korea, Portfolio Analysis, 2000-2012
    • Table 9: Drug Delivery Devices, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 10: Drug Delivery Devices, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 11: Drug Delivery Devices, Republic of Korea, Category Volume (Units), 2000-2012
    • Table 12: Drug Delivery Devices, Republic of Korea, Category Volume (Units), Historic, 2000-2007
    • Table 13: Drug Delivery Devices, Republic of Korea, Category Volume (Units), Forecast, 2007-2012
    • Table 14: Drug Delivery Devices, Republic of Korea, Company Share by Revenue ($ mn), 2006-2007
    • Table 15: Infusion Systems, Republic of Korea, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Table 16: Infusion Systems, Republic of Korea, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Table 17: Infusion Systems, Republic of Korea, Overall Volume (Units), Historic, 2000-2007
    • Table 18: Infusion Systems, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012
    • Table 19: Infusion Systems, Republic of Korea, Average Price ($), Historic, 2000-2007
    • Table 20: Infusion Systems, Republic of Korea, Average Price ($), Forecast, 2007-2012
    • Table 21: Infusion Systems, Republic of Korea, Distribution Share by Revenue ($mn), 2006-2007
    • Table 22: Infusion Systems, Republic of Korea, Company Share by Revenue ($ mn), 2006-2007
    • Table 23: Inhalation Systems, Republic of Korea, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Table 24: Inhalation Systems, Republic of Korea, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Table 25: Inhalation Systems, Republic of Korea, Overall Volume (Units), Historic, 2000-2007
    • Table 26: Inhalation Systems, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012
    • Table 27: Inhalation Systems, Republic of Korea, Average Price ($), Historic, 2000-2007
    • Table 28: Inhalation Systems, Republic of Korea, Average Price ($), Forecast, 2007-2012
    • Table 29: Inhalation Systems, Republic of Korea, Distribution Share by Revenue ($mn), 2006-2007
    • Table 30: Inhalation Systems, Republic of Korea, Company Share by Revenue ($ mn), 2006-2007
    • Table 31: Currency Conversion from USD to Local Currency at 2007 Constant Rate
  • 1.2 List of Figures
    • Figure 1: Healthcare Financing in Republic of Korea, 2007
    • Figure 2: Healthcare Expenditure in Republic of Korea, 2000 - 2006
    • Figure 3: Evaluation (Value Appraisal) Criteria for Medical Device Reimbursement in Republic of Korea, 2007
    • Figure 4: Medical Device Pricing System in Republic of Korea, 2007
    • Figure 5: Drug Delivery Devices Cross Country Comparison (2000-2012)
    • Figure 6: Drug Delivery Devices, Republic of Korea, Overall Revenues ($ mn), 2000-2012
    • Figure 7: Drug Delivery Devices, Republic of Korea, Portfolio Analysis, 2000-2012
    • Figure 8: Drug Delivery Devices, Republic of Korea, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 9: Drug Delivery Devices, Republic of Korea, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 10: Drug Delivery Devices, Republic of Korea, Category Volume (Units), 2000-2012
    • Figure 11: Drug Delivery Devices, Republic of Korea, Category Volume (Units), Historic, 2000-2007
    • Figure 12: Drug Delivery Devices, Republic of Korea, Category Volume (Units), Forecast, 2007-2012
    • Figure 13: Drug Delivery Devices, Republic of Korea, Company Share (%), 2007
    • Figure 14: Infusion Systems, Republic of Korea, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Figure 15: Infusion Systems, Republic of Korea, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Figure 16: Infusion Systems, Republic of Korea, Company Share (%), 2007
    • Figure 17: Inhalation Systems, Republic of Korea, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Figure 18: Inhalation Systems, Republic of Korea, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Figure 19: Inhalation Systems, Republic of Korea, Overall Volume (Units), Historic, 2000-2007
    • Figure 20: Inhalation Systems, Republic of Korea, Overall Volume (Units), Forecast, 2007-2012
    • Figure 21: Inhalation Systems, Republic of Korea, Company Share (%), 2007
    • Figure 22: 3M Healthcare Value Chain Analysis
    • Figure 23: Boehringer Ingelheim GmbH Value Chain Analysis
    • Figure 24: Cardinal Health, Inc. Value Chain Analysis
    • Figure 25: Global Markets Direct Methodology